LGC publishes ESG report for 2021-22
This is LGC’s second ESG report using the Global Reporting Initiative (GRI) Standards, the most widely used sustainability reporting framework globally.
Read MoreNews
To contact the press office please email or call +44 7408 850 514
Infectious disease researchers publish routes to ensure lessons are learned from COVD-19 when using PCR for monkeypox diagnosis
The paper, titled “Monkeypox: another test for PCR”, focuses on how to ensure the PCR diagnosis tests being deployed for monkeypox will be most accurate and that lessons learned on PCR testing from the COVID-19 pandemic are applied to the current epidemic.
Read MoreLGC Clinical Diagnostics extend collaboration with Stanford Medicine supporting global genetic and metabolomic diagnostic testing
The exclusive partnership will also be extended to include the analysis of phenotypic-genotypic correlations and metabolic profiling of some common maternal/ fetal cardiac defects known to be related to monogenic disorders.
Read MoreLGC launches free app-based cannabis testing training to support cannabis testing laboratories in their learning
Easy-to-use app-based microlearning provides training in a range of cannabis-related topics
Read MoreLGC to distribute InBio’s food allergen reference materials and immunoassays
Expands LGC’s offering to more than 180 allergen reference materials for a range of applications including method development and method verification
Read MoreLGC Board Change
Update
Read MoreLGBTQ scientists throughout history and the future
As we continue to celebrate Pride month, let’s take a look at several famous LGBTQ scientists throughout history that have changed and continue to change the world.
Read MoreNational agrifood partnership launched at Queen’s University Belfast
We're pleased to launch the Centre for Excellence in Agriculture and Food Integrity, a strategic partnership to enhance and future-proof the UK agrifood industry through the development and application of innovative scientific-measurement solutions and digital technologies for greater assurance of the sustainability, reliability, safety and productivity of inherent supply chains.
Read MoreAmpersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder
DDS is a European provider of Bioanalytical and Analytical and Materials Science Solutions to pharma, biopharma, consumer healthcare and consumer products clients, located in Cambridge and Sandwich, UK
Read MoreEnabling the recycling of technology critical elements from e-waste
our Inorganic Analysis team at the UK National Measurement Laboratory at LGC are working with partners across Europe and the recycling industry to develop and underpin analytical methods to determine the presence of technology critical elements, within electronic waste samples. This knowledge can then be used by the industry to determine suitable recycling pathways and promote the reuse of TCEs.
Read MoreLGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA
Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing
Read MoreSuccessful completion of leading TNAC’s new home at Oxford Technology Park
Purpose-built R and D and manufacturing facility will be a vital hub for LGC
Read More